The Institute for Immunology and Informatics (iCubed) at the University of Rhode Island held its seventh annual Vaccine Renaissance Conference in Providence, Rhode Island on October 16-18, 2013.
This year’s conference provided a one-of-a-kind forum for focused discussion on today’s most significant infectious disease threats. iCubed hopes to continue to broaden awareness of new methods that will improve vaccine efficacy and safety, as well as concentrate on the crucial role vaccines play in human health. Last winter’s influenza epidemic is a stark reminder of the importance of vaccination.
The conference was comprised of several different sessions covering topics including cancer immunotherapeutics, gut microbiome, immune modulation, heterologous immunity, biodefense, emerging infectious diseases, neglected tropical diseases and a “one health” session focusing on diseases impacting humans and animals.
This year’s gathering was scheduled over the course of three days. Our TRIAD Toolkit training took place on Wednesday, October 16 on the Providence campus of the University of Rhode Island. The conference were held on Thursday, October 17 and Friday, October 18 inside the conference space of the Hotel Providence.
Vaccine Renaissance Conference Speakers:
- Alan Barrett, Ph.D. Director, Sealy Center for Vaccine Development, University of Texas Medical Branch
- Biswajit Biswas, Ph.D., Scientist, Naval Medical Research Center
- Clare Fraser, Ph.D., Director, Institute for Genome Sciences, University of Maryland School of Medicine
- Ken Ishii, M.D., Ph.D., Professor, Immunology Frontier Research Center, NIBIO/Osaka University (Japan)
- Philip Russell, M.D., Ph.D., Founding President, The Albert B. Sabin Vaccine Institute
- Justin Skoble, Ph.D., Director, Biodefense and Process Development, Aduro Biotech
- Dan Shelley, M.D., Ph.D., Director, Strategic Accounts, Novozymes Biopharma
- Marcelo Sztein, M.D., Professor, University of Maryland School of Medicine
- James B. Trager, Ph.D., Vice President, Research, Dendreon Corporation
- Paulo Verardi, Ph.D., Assistant Professor, Department of Pathobiology and Veterinary Science, University of Connecticut
- Nathan VerBerkmoes, Ph.D., Staff Scientist, Chemical Biology Division, New England Biolabs, Inc.
- Jack Wands, M.D., Director, Liver Research Center, Rhode Island Hospital
- Joel Weinstock, M.D., Chief of the Division of Gastroenterology/Hepatology, Tufts Medical Center
Wednesday, October 16 – Friday, October 18
Day 1: URI Feinstein Campus – (Downtown Providence) University of Rhode Island
Day 2-3: Hotel Providence – 139 Mathewson Street, Providence, RI 02903